These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19343478)

  • 61. The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia.
    Jiang S; Wang Y; Shi W; Shao Y; Qiao X; Lin J; Kuang H; Xie X
    Pediatr Hematol Oncol; 2009; 26(5):313-20. PubMed ID: 19579077
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Clinical characteristics of clonal evolution after immunosuppressive therapy in children with severe/very severe aplastic anemia].
    Zhang JL; Liu TF; Chang LX; Chen X; Ren YY; Sun CC; Liu C; An WB; Wan Y; Chen XJ; Yang WY; Wang SC; Guo Y; Zou Y; Chen YM; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jan; 19(1):27-33. PubMed ID: 28100318
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunosuppressive therapy for acquired severe aplastic anemia (SAA): a prospective comparison of four different regimens.
    Zheng Y; Liu Y; Chu Y
    Exp Hematol; 2006 Jul; 34(7):826-31. PubMed ID: 16797409
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Markedly High Plasma Thrombopoietin (TPO) Level is a Predictor of Poor Response to Immunosuppressive Therapy in Children With Acquired Severe Aplastic Anemia.
    Elmahdi S; Muramatsu H; Narita A; Ismael O; Hama A; Nishio N; Okuno Y; Xu Y; Wang X; Takahashi Y; Kojima S
    Pediatr Blood Cancer; 2016 Apr; 63(4):659-64. PubMed ID: 26575027
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nutritional status survey of aplastic anemia patients--a single center experience in China.
    Li X; Feng Y; Wang H; Song M; Jin J; Cui Z; Zheng Y
    Appl Nurs Res; 2016 May; 30():142-7. PubMed ID: 27091269
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Outcome of children with aplastic anemia treated with immunosuppressive therapy.
    Pongtanakul B; Das PK; Charpentier K; Dror Y
    Pediatr Blood Cancer; 2008 Jan; 50(1):52-7. PubMed ID: 17941069
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tacrolimus as an alternative to cyclosporine in the maintenance phase of immunosuppressive therapy for severe aplastic anemia in children.
    Alsultan A; Goldenberg NA; Kaiser N; Graham DK; Hays T
    Pediatr Blood Cancer; 2009 May; 52(5):626-30. PubMed ID: 19148946
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular alterations in the TCR signaling pathway in patients with aplastic anemia.
    Li B; Guo L; Zhang Y; Xiao Y; Wu M; Zhou L; Chen S; Yang L; Lu X; Li Y
    J Hematol Oncol; 2016 Mar; 9():32. PubMed ID: 27036622
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Long-term follow-up of malignant clonal evolution in patients with acquired aplastic anemia].
    Li XX; Ge ML; Shi J; Feng XY; Shao YQ; Qian LS; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):463-7. PubMed ID: 22213866
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Aplastic anaemia in childhood: prognosis and approach to therapy.
    Windass B; Vowels MR; Hughes DO; White L
    Med J Aust; 1987 Jan; 146(1):15-9. PubMed ID: 3540547
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Outcome of pediatric acquired aplastic anemia: a developing world experience.
    Ramzan M; Yadav SP; Zafar MS; Dinand V; Sachdeva A
    Pediatr Hematol Oncol; 2014 Feb; 31(1):29-38. PubMed ID: 23802844
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Coexistence of normal and clonal haemopoiesis in aplastic anaemia patients treated with immunosuppressive therapy.
    Piaggio G; Podestà M; Pitto A; Sessarego M; Figari O; Fugazza G; Benvenuto F; Bruno B; Van Lint MT; Truini M; Frassoni F; Bacigalupo A
    Br J Haematol; 1999 Dec; 107(3):505-11. PubMed ID: 10583249
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Increased immunosuppressive treatment combined with unrelated umbilical cord blood infusion in children with severe aplastic anemia.
    Xie LN; Fang Y; Yu Z; Song NX; Kong FS; Liu XM; Zhou F
    Cell Immunol; 2014; 289(1-2):150-4. PubMed ID: 24838091
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study.
    Xu LP; Wang SQ; Ma YR; Gao SJ; Cheng YF; Zhang YY; Mo WJ; Mo XD; Zhang YP; Yan CH; Chen YH; Zhou M; Wang Y; Zhang XH; Liu KY; Huang XJ
    J Hematol Oncol; 2019 Sep; 12(1):87. PubMed ID: 31477147
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Change and significance of Th22 cells in patients with aplastic anemia].
    Liu LM; Zhang XX; Zhao GS; Si YJ; Lin GQ; Zhang YM; He GS; Wu DP
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(20):1537-40. PubMed ID: 24028718
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia.
    Lu Y; Sun RJ; Zhao YL; Xiong M; Cao XY; Zhang JP; Wei ZJ; Zhou JR; Liu DY; Lu DP
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1881-1887. PubMed ID: 29772350
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of frontline treatment with intensive immunosuppression therapy and HLA-haploidentical hematopoietic stem cell transplantation for young patients with severe aplastic anemia - A meta analysis.
    Geng C; Liu X; Chen M; Yang C; Han B
    Leuk Res; 2020 Jan; 88():106266. PubMed ID: 31743865
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of Outcomes of Frontline Immunosuppressive Therapy and Frontline Haploidentical Hematopoietic Stem Cell Transplantation for Children with Severe Aplastic Anemia Who Lack an HLA-Matched Sibling Donor.
    Yang S; Yuan X; Ma R; Jiang L; Guo J; Zang Y; Shi J; Yang J; Lei P; Liu Z; Zhang Y; Zhu Z
    Biol Blood Marrow Transplant; 2019 May; 25(5):975-980. PubMed ID: 30658223
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.
    Marsh J; Schrezenmeier H; Marin P; Ilhan O; Ljungman P; McCann S; Socie G; Tichelli A; Passweg J; Hows J; Raghavachar A; Locasciulli A; Bacigalupo A
    Blood; 1999 Apr; 93(7):2191-5. PubMed ID: 10090926
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evolution of iron burden in acquired aplastic anemia: a cohort study of more than 3-year follow-up.
    Jin P; Wang J; Li X; Wang M; Ge M; Zhang J; Huang J; Zhang J; Huang Z; Nie N; Shao Y; Shi J; Zheng Y
    Int J Hematol; 2015 Jan; 101(1):13-22. PubMed ID: 25430083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.